Point of care testing
Showing 1 - 25 of >10,000
Bilistick Point-of-care System 2.0 Bilirubin Validation
Not yet recruiting
- Neonatal Screening
- +3 more
- Bilistick System 2.0 point-of-care testing device
- (no location specified)
Sep 27, 2023
The National Australian HCV Point-of-Care Testing Program - HCV
Not yet recruiting
- Hepatitis C
- Diagnostic Test: Point-of-Care Testing
- (no location specified)
Feb 1, 2023
Urin-based Point-of-Care Testing for Direct Oral Anticoagulants
Recruiting
- Stroke
- Urin-based test by the DOASENSE Dipstick Device
-
Gießen, Hesse, GermanyDepartment of Neurology, University Hospital Giessen
Sep 13, 2023
Hemoglobin Testing in Pregnant Patients
Not yet recruiting
- Post Partum Hemorrhage
- Anemia of Pregnancy
- Masimo Root Radical 7 Pulse CO-Oximeter
- HemoCue Hb 801
- (no location specified)
Jul 28, 2023
Point-of-Care Test for Coagulation Function
Not yet recruiting
- CoaguChek® XS System
- Coagulation Function
- Coaguchek testing
- (no location specified)
Sep 7, 2023
Syphilis, HIV Trial in Regina (Reveal Rapid TP (from MedMira))
Recruiting
- Syphilis
- HIV Infections
- Reveal Rapid TP (from MedMira)
-
Regina, Saskatchewan, Canada
- +1 more
May 8, 2023
Lower Resp Tract Infection Trial (FebriDx)
Not yet recruiting
- Lower Resp Tract Infection
- FebriDx
- (no location specified)
Sep 7, 2022
The National Australian HCV Point-of-Care Testing Program -
Not yet recruiting
- Hepatitis C
- Point-of-Care Testing
- (no location specified)
Feb 9, 2022
HIV/AIDS, HIV-1-infection Trial in Durban (Point-of-care viral load testing and tenofovir adherence testing)
Recruiting
- HIV/AIDS
- HIV-1-infection
- Point-of-care viral load testing and tenofovir adherence testing
-
Durban, KwaZulu-Natal, South AfricaCentre for the AIDS Programme of Research in South Africa (CAPRI
Nov 16, 2022
Sexually Transmitted Infection, Chlamydia, Gonorrhea Trial (Point-of-care STI testing)
Not yet recruiting
- Sexually Transmitted Infection
- +8 more
- Point-of-care STI testing
- (no location specified)
Sep 12, 2022
HIV Trial in Gaborone (Point-of-Care Cepheid Xpert HIV-1, DTG/ABC/3TC)
Recruiting
- HIV
- Point-of-Care Cepheid Xpert HIV-1
- DTG/ABC/3TC
-
Gaborone, BotswanaBotswana Harvard HIV/AIDS Institute Partnership
Jul 5, 2022
Repeatability of NT-proBNP Testing Using Laboratory and Point of
Active, not recruiting
- Pulmonary Artery Hypertension
- Exercise group
-
Sheffield, South Yorkshire, United KingdomPulmonary Vascular Disease Unit, Royal Hallamshire Hospital
Jun 14, 2022
Streptococcal Pharyngitis Trial in Hamilton (Rapid testing, Reference testing)
Recruiting
- Streptococcal Pharyngitis
- Rapid testing
- Reference testing
-
Hamilton, Ontario, CanadaMcMaster Children's Hospital
Jan 5, 2023
Anticoagulation and Thrombosis Point of Care Test (AT-POCT) Trial in Durham (Anticoagulation and Thrombosis Point of Care
Not yet recruiting
- Anticoagulation and Thrombosis Point of Care Test (AT-POCT)
- Anticoagulation and Thrombosis Point of Care Test(AT-POCT)
- Duke Central Automated Laboratory (DCAL)
-
Durham, North CarolinaDuke University Medical Center
Mar 21, 2022
Communicable Disease, COVID-19, Sars-CoV2 Trial in Northglenn (COVID-19 Antigen/Antibody Rapid Testing, mobile device image
Recruiting
- Communicable Disease
- +5 more
- COVID-19 Antigen/Antibody Rapid Testing, mobile device image capture and telemedicine support
- Telemedicine
-
Northglenn, ColoradoNeuroganics
Mar 8, 2022
Hepatitis C Trial in Sydney (HCV RNA Point of Care, Sofosbuvir/velpatasvir, Glecaprevir/pibrentasvir)
Recruiting
- Hepatitis C
- HCV RNA Point of Care
- +2 more
-
Sydney, New South Wales, AustraliaNUAA NSP
Aug 19, 2022
Tuberculosis Infection, Isoniazid Adverse Reaction Trial (Low-dose isoniazid, Standard dose of isoniazid, High-dose isoniazid)
Not yet recruiting
- Tuberculosis Infection
- Isoniazid Adverse Reaction
- Low-dose isoniazid
- +2 more
- (no location specified)
Jun 7, 2022
Anticoagulant Therapy Trial in Mannheim (Apixaban 5 MG Tab, Dabigatran 150 MG Tab, Edoxaban 60Mg Tab)
Active, not recruiting
- Anticoagulant Therapy
- Apixaban 5 MG Tab
- +3 more
-
Mannheim, GermanyClincial Research Serivces
Aug 4, 2022
(EID) Versus Standard of Care EID- Long Term Impact on inFant
Active, not recruiting
- HIV, Neonatal HIV Early-Infant-Diagnosis (EID), Point-of-Care Testing (PoC)
- point-of care (PoC) neonatal HIV early infant diagnosis (EID)
-
Beira, Sofala, Mozambique
- +1 more
Aug 5, 2022
Antimicrobial Stewardship, Exacerbation of Allergic Asthma, Exacerbation Copd Trial in Hannover (Point-of-care Test)
Completed
- Antimicrobial Stewardship
- +4 more
- Point-of-care Test
-
Hannover, Lower Saxony, GermanyMedical School Hannover
May 18, 2022
Tuberculosis Trial in Cape Town (Xpert Ultra Point of Care testing)
Completed
- Tuberculosis
- Xpert Ultra Point of Care testing
-
Cape Town, Western Cape, South Africa
- +1 more
Nov 1, 2022
Diabetes, Type 2 Trial in Herlev, Hillerød (Dexcom G6 Continuous Glucose Monitoring System (Dexcom Inc., San Diego, USA),
Not yet recruiting
- Diabetes Mellitus, Type 2
- Dexcom G6 Continuous Glucose Monitoring System (Dexcom Inc., San Diego, USA)
- FreeStyle Precision Pro Glucometer for glucose POC testing
-
Herlev, Denmark
- +1 more
Mar 27, 2023
Point-of-care Testing Instrument for Fecal Immunochemical Test
Not yet recruiting
- Colorectal Cancer
- The new instrument and colonoscopy with pathological examination
-
Jinan, Shandong, ChinaQilu Hospital
Feb 9, 2022
Covid19 Trial in Bronx, Long Island City (Onsite Point-of-care)
Recruiting
- Covid19
- Onsite Point-of-care
-
Bronx, New York
- +1 more
Jan 7, 2023
Constipation Trial in Lebanon (Rectal Expulsion Device (RED) - Feasibility, Rectal Expulsion Device (RED) - Validation)
Completed
- Constipation
- Rectal Expulsion Device (RED) - Feasibility
- Rectal Expulsion Device (RED) - Validation
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Jan 18, 2022